10x Genomics (TXG) FCF Margin (2018 - 2026)

10x Genomics has disclosed FCF Margin across 9 years of filings, most recently posting 17.24% for Q1 2026.

• FCF Margin for Q1 2026 came in at 17.24%, down 372.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 19.36% (up 1226.0% YoY), and the FY2025 annual result was 20.24%, up 2118.0% from the prior year.
• FCF Margin came in at 17.24% for Q1 2026 at 10x Genomics, down from 23.49% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 28.54% in Q3 2025 to a low of 56.74% in Q4 2022.
• The 5-year median for FCF Margin is 2.36% (2024), against an average of 2.82%.
• Peak annual rise in FCF Margin reached 8630 bps in 2022, while the deepest fall reached 10028 bps in 2022.
• 10x Genomics' FCF Margin stood at 56.74% in 2022, then surged by 124 bps to 13.77% in 2023, then sank by 180 bps to 11.02% in 2024, then soared by 313 bps to 23.49% in 2025, then fell by 27 bps to 17.24% in 2026.
• The last three FCF Margin figures came in at 17.24% (Q1 2026), 23.49% (Q4 2025), and 28.54% (Q3 2025), per Business Quant data.